{"prompt": "['SANOFI', 'NCT Number: NCT03236311', 'AMENDED CLINICAL TRIAL PROTOCOL NO 03', 'COMPOUND: SAR407899', 'A randomized, double-blind, placebo-controlled parallel arm dose titration study to', 'assess the effects of SAR407899 in patients with microvascular angina and/or', 'persistent stable angina despite angiographically successful percutaneous', 'coronary intervention', 'STUDY NUMBER: ACT14656', 'VERSION DATE / STATUS: Approval date (18-Apr-2018) / Approved', 'Protocol Amendment 04', 'Version number: 1 (electronic 1.0)', 'Date : 18-Apr-2018', 'Amended Clinical Trial Protocol 03 (local', 'Version number: 1 (electronic 3.0)', 'Date : 05-Dec-2017', 'for Sweden)', 'Amended Clinical Trial Protocol 02', 'Version number: 1 (electronic 3.0)', 'Date : 05-Dec-2017', 'Protocol Amendment 03', 'Version number: 1 (electronic 2.0)', 'Date : 05-Dec-2017', 'Amended Clinical Trial Protocol 02 (local', 'Version number: 1 (electronic 1.0)', 'Date : 11-Sep-2017', 'for Sweden)', 'Protocol Amendment 02 (local for Sweden) Version number: 1 (electronic 1.0)', 'Date : 11-Sep-2017', 'Amended Clinical Trial Protocol 01', 'Version number: 1 (electronic 1.0)', 'Date : 31-Mar-2017', 'Protocol Amendment 01', 'Version number: 1 (electronic 1.0)', 'Date : 31-Mar-2017', 'Clinical Trial Protocol', 'Version number: 1 (electronic 1.0)', 'Date : 07-Jul-2016', 'Version Number:', '1', 'EudraCT Number:', '2016-000629-38', 'IND Number:', '129855', 'WHO Universal Trial Number:', 'U1111-1182-1709', 'Date:', '18-Apr-2018', 'Total number of pages:', '108', 'Any and all information presented in this document shall be treated as confidential and shall remain the exclusive property of Sanofi (or any of its', 'affiliated companies). The use of such confidential information must be restricted to the recipient for the agreed purpose and must not be', 'disclosed, published or otherwise communicated to any unauthorized persons, for any reason, in any form whatsoever without the prior written', 'consent of Sanofi (or the concerned affiliated company); \"affiliated company means any corporation, partnership or other entity which at the date', \"of communication or afterwards (i) controls directly or indirectly Sanofi, (ii) is directly or indirectly controlled by Sanofi, with 'control' meaning\", 'direct or indirect ownership of more than 50% of the capital stock or the voting rights in such corporation, partnership or other entity', 'According to template: QSD-003152 VERSION N\u00b03.0 (04-FEB-2016)', 'Page 1', '(electronic 4.0)']['Amended Clinical Trial Protocol NO 03', '18-Apr-2018', 'ACT14656', 'Version number: 1', 'NAMES AND ADDRESSES OF', 'COORDINATING', 'Name:', 'INVESTIGATOR', 'Address:', 'Tel:', 'Fax:', 'E-mail:', \"MONITORING TEAM'S\", 'Name:', 'To be filled in by each CSU participating in the', 'REPRESENTATIVE', 'Address:', 'study', 'Tel:', 'Fax:', 'E-mail:', 'SPONSOR', 'Company:', 'sanofi-aventis Recherche & D\u00e9veloppement', 'Address:', '1, Avenue Pierre Brossolette', '91385 Chilly Mazarin - France', 'OTHER EMERGENCY', 'TELEPHONE NUMBERS', 'Property of the Sanofi Group - strictly confidential', 'Page 2', '(electronic 4.0)']\n\n###\n\n", "completion": "END"}